Carina Henningsson

Title: Carina Henningsson: Innovator in Cellular Immune Response Enhancement

Introduction

Carina Henningsson is a notable inventor based in Edmonton, Canada. She has made significant contributions to the field of immunology, particularly in enhancing the cellular immune response. With a total of 4 patents to her name, Henningsson's work has the potential to impact cancer therapy and prophylaxis.

Latest Patents

Henningsson's latest patents focus on the enhancement of the cellular immune response through the use of DTH-Effector cells. These cells are primed with carbohydrate antigens, which have shown efficacy in inhibiting tumors. Specifically, DTH-Effector cells primed with epiglycanin and synthetic T and Tn antigens can be utilized for tumor prophylaxis and therapy. This innovative approach highlights her commitment to advancing cancer treatment methodologies.

Career Highlights

Throughout her career, Henningsson has been associated with Biomira, Inc., where she has been able to apply her research and innovations in a practical setting. Her work has garnered attention in the scientific community, showcasing her expertise and dedication to improving health outcomes.

Collaborations

Henningsson collaborates with B Michael Longenecker, further enhancing her research capabilities and expanding the impact of her work in the field of immunology.

Conclusion

Carina Henningsson's contributions to the enhancement of the cellular immune response represent a significant advancement in cancer therapy. Her innovative patents and collaborative efforts continue to pave the way for future breakthroughs in immunology.